Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Voyager Therapeutics: Q4 Earnings Snapshot
By AP News - Mar 11, 2025, 04:26 PM ET
Last Updated - Mar 11, 2025, 04:26 PM EDT
LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Voyager Therapeutics Inc. (VYGR) on Tuesday reported a loss of $34.5 million in its fourth quarter.
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 59 cents.
Sponsored
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 35 cents per share.
The gene therapy company posted revenue of $6.3 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $20.1 million.
For the year, the company reported a loss of $65 million, or $1.13 per share. Revenue was reported as $80 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VYGR at https://www.zacks.com/ap/VYGR
Sponsored
Read More from Investing
Popular News
Latest News
